Corporate & FMCG
New Delhi | Economy India | Amway India Enterprises Pvt Ltd, one of the country’s leading direct-selling companies, reported a widening of losses to ₹74.25 crore in FY25, even as its revenue from operations declined by over 10 per cent, reflecting sustained pressure on sales, margins, and operating environment.
According to regulatory filings accessed through business intelligence platform Tofler, Amway India’s revenue from operations fell 10.56 per cent year-on-year to ₹1,148.16 crore in the financial year ended March 31, 2025. In comparison, the company had posted revenue of ₹1,283.75 crore in FY24.
The company’s total income, which includes other income, also declined by 9.2 per cent to ₹1,174.85 crore in FY25, from ₹1,293.79 crore in the previous financial year.
Losses Deepen Despite Cost Controls
Amway India’s net loss widened to ₹74.25 crore in FY25, compared with a loss of ₹53.38 crore in FY24, indicating an additional erosion of profitability by nearly ₹21 crore over the year.
Industry analysts attribute the widening losses to:
- Sluggish demand in discretionary wellness and nutrition categories
- Higher operating and compliance costs
- Intense competition from digital-first wellness brands
- Continued regulatory scrutiny on the direct-selling sector
Despite efforts to rationalise costs and optimise operations, the decline in topline appears to have outweighed efficiency measures.
Sales Performance Reflects Challenging Market Conditions
Amway India operates across categories such as nutrition, health supplements, personal care, beauty, and home care, with a business model dependent on a large network of direct sellers.
However, FY25 proved challenging due to:
- Softer urban consumption trends
- Increased price sensitivity among consumers
- Shift towards online marketplaces and D2C brands
- Moderation in discretionary spending post-pandemic rebound
The decline of over ₹135 crore in operational revenue highlights the pressure faced by legacy direct-selling players in a rapidly evolving retail ecosystem.
Comparison with Previous Financial Year
In FY24, Amway India had already reported financial stress, with:
- Revenue from operations at ₹1,283.75 crore
- Net loss of ₹53.38 crore
The further deterioration in FY25 underscores that the turnaround has taken longer than expected, amid structural and market-level headwinds.
Regulatory and Competitive Landscape
The direct-selling industry in India has been undergoing a phase of regulatory transition, with stricter compliance norms, state-level enforcement actions, and evolving guidelines aimed at distinguishing legitimate direct selling from pyramid schemes.
This has led to:
- Higher compliance and legal costs
- Operational restructuring
- Increased caution in distributor onboarding and incentives
At the same time, the rise of digital wellness brands, influencer-led commerce, and e-pharmacies has intensified competition, forcing traditional players like Amway to rethink distribution and marketing strategies.
Strategic Focus Areas Going Forward
While the company has not issued detailed forward-looking guidance, industry observers expect Amway India to focus on:
- Strengthening digital and omni-channel capabilities
- Product innovation in nutrition and wellness segments
- Cost optimisation and operational efficiency
- Enhancing distributor productivity and engagement
Any sustained recovery in profitability is likely to depend on revival in consumer demand, successful adaptation to digital channels, and stabilisation of regulatory conditions.
Industry Outlook
Despite near-term challenges, India remains one of the largest and fastest-growing direct-selling markets globally, driven by:
- Rising health awareness
- Expanding middle class
- Growing demand for nutrition and wellness products
However, analysts caution that companies with traditional models will need to modernise rapidly to remain competitive against agile, technology-driven players.
Financial Snapshot: Amway India (FY24 vs FY25)
| Particulars | FY24 | FY25 | YoY Change |
|---|---|---|---|
| Revenue from Operations | ₹1,283.75 crore | ₹1,148.16 crore | ▼ 10.56% |
| Total Income | ₹1,293.79 crore | ₹1,174.85 crore | ▼ 9.20% |
| Net Profit / (Loss) | (₹53.38 crore) | (₹74.25 crore) | Loss widened |
Source: Company filings; Tofler
Amway India’s FY25 performance reflects a difficult operating environment, marked by falling sales and widening losses. While the company continues to be a significant player in India’s wellness and nutrition space, the financials highlight the urgency for strategic recalibration.
The coming years will be crucial in determining whether Amway India can reverse the revenue decline, restore profitability, and reposition itself in an increasingly competitive and digitally driven consumer market.
(Economy India)
